Diffusion-weighted MRIs in an acute leukoencephalopathy following intrathecal chemotherapy

Neurology

Volumn 62, Issue 5, 2004, Pages 832-833

  Lee, Sonn Tae ^a   Kim, Manho ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DOSE RESPONSE; HUMAN; LEUKOENCEPHALOPATHY; MALE; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 1542316156     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000113753.47685.36     Document Type: Article

References (7)

1. Filley CM. Toxic leukoencephalopathy. Clin Neuropharmacol 1999;22: 249-260.
2. Walker RW, Allen JC, Rosen G, Caparros B. Transient cerebral dysfunction secondary to high-dose methotrexate. J Clin Oncol 1986;4:1845-1850.
3. Mahoney DH, Shuster JJ, Nitschke R, et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy - a Pediatric Oncology Group study. J Clin Oncol 1998;16:1712-1722.
4. Hwang TL, Yung A, Estey EH, Fields WS. Central nervous system toxicity with high-dose Ara-C. Neurology 1985;35:1475-1479.
5. Quinn CT, Griener JC, Bottiglieri T, Hyland K, Farrow A, Kamen BA. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for treatment of cancer. J Clin Oncol 1997;15:2800-2806.
6. Shaefer PW, Grant PE, Gonzalez RG, et al. Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331-345.
7. Shibutani M, Okeda R. Experimental study on subacute neurotoxicity of methotrexate in cats. Acta Neuropathol 1989;78:291-300.